Legend Innovation Life Science Fund announced an investment commitment of up to $50 million in Mid-Atlantic BioTherapeutics, a clinical-stage biotechnology company headquartered in Pennsylvania and focused on advancing novel therapies for anti-aging, including neurological diseases and cancer.